You are here

Article Text

Article menu
Download PDFPDF
Proliferation and neoplasia
Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours
  1. S Angelettia,
  2. V D Corletoa,
  3. O Schillacib,
  4. M Marignania,
  5. B Annibalea,
  6. A Morettia,
  7. G Silecchiac,
  8. F Scopinarob,
  9. N Bassoc,
  10. C Bordid,
  11. G Delle Favea
  1. aDepartment of Gastroenterology, University “La Sapienza”, Rome, Italy, bDepartment of Nuclear Medicine, cDepartment of Surgery, dDepartment of Pathology, University of Parma, Parma, Italy
  1. Dr G Delle Fave, Cattedra di Gastroenterologia I, Clinica Medica 2, Policlinico Umberto I°, 00161 Roma, Italy.

Abstract

Background—Somatostatin receptor scintigraphy (SRS) and octreotide therapy have both changed the management of gastroenteropancreatic endocrine tumours, but very few data are available on the use of SRS and octreotide to visualise and treat somatostatinomas.

Method—The results of SRS and octreotide treatment in three somatostatinoma patients were examined.

Results—SRS was able to detect extensive hepatic involvement in patient 1, one hepatic and one pancreatic lesion in patient 2, and one hepatic lesion in patient 3. Octreotide therapy (0.5 mg/day subcutaneously) was effective in decreasing plasma levels of somatostatin in all three patients. Symptoms (diabetes and diarrhoea) were greatly improved in the two patients with “somatostatinoma syndrome”.

Conclusion—The study shows that somatostatinoma, like most other gastroenteropancreatic endocrine tumours, possesses functioning somatostatin receptors.

  • somatostatin
  • octreotide
  • somatostatin receptor scintigraphy
  • gastroenteropancreatic endocrine tumour
  • somatostatinoma

https://doi.org/10.1136/gut.42.6.792

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text